Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00135265 · ClinicalTrials.gov registry record · Phase 1
PROS Smokebusters: Adolescent Smoking Cessation in Pediatric Primary Care
A Phase 1 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 1
- Development phase
- 4,100
- Enrollment target
NCT00135265: Completed Phase 1 study, sponsored by University of Rochester.
NCT00135265 is a Phase 1 study that has completed, run by University of Rochester. The registered enrollment target is 4,100 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (6733% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00135265, a Phase 1 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4,100 participants
- Enrollment target
Study Summary
This is a pilot study addressing office systems and clinician behavior change surrounding smoking cessation interventions for teens. The investigators' long-term goal is to improve the quality of clinical preventive services in practice-based research network settings. Their specific aims are to: * a) pilot procedures for recruitment and randomization of PROS practices; and b) field trial/pilot PROS practitioner cessation counseling and practices' enrollment of adolescent patients; and * assess the feasibility of pediatric clinician referral of adolescent patients to internet-based adjuncts for smoking cessation. The investigators will evaluate a pilot round of recruitment and randomization, and smoking cessation training and delivery in 10 PROS practice sites; and assess the acceptability of study procedures and on-line internet counseling adjunct referral feasibility within PROS practice sites. Up to 1000 adolescents presenting for well visits will complete a short baseline survey prior to their well-visit. A sample of them will be surveyed by phone at 4-6 weeks to provide preliminary estimates of cessation counseling effectiveness for future studies. The investigators will field test measures, describe the patterns of smoking among youth, and explore how much receiving interventions affects motivation, quitting, abstinence/relapse attitudes, attitudes towards internet-based outreach strategies, and behaviors for 100 smokers. \*\*we have completed recruitment of providers; we are recruiting teens ONLY at this point\*\*
Interventions
- BEHAVIORAL smoking cessation, practice change
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,100 participants |
| Start Date | 2006-10 |
| Est. Completion | 2010-01 |
| Phase | Phase 1 |
What the finished NCT00135265 record still lists
NCT00135265 is an interventional study that assigns participants to a tested intervention. Its 4,100 participants enrollment target places it among the larger protocols in the corpus, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (6733% higher).
The record links to 0 conditions, and to 1 intervention - of which smoking cessation, practice change is the first listed.
NCT00135265 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00135265 about?
NCT00135265 is a clinical study titled "PROS Smokebusters: Adolescent Smoking Cessation in Pediatric Primary Care". This is a pilot study addressing office systems and clinician behavior change surrounding smoking cessation interventions for teens. The investigators' long-term goal is to improve the quality of clinical preventive services in practice-based research network settings. Their specific aims are to: *...
What is the current status of trial NCT00135265?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4,100 participants. The study started on 2006-10. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00135265?
The interventions under investigation include: smoking cessation, practice change (BEHAVIORAL).
Who is sponsoring clinical trial NCT00135265?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00135265's enrollment target sits among peer trials
4,100 1st of 2000 higher than 2,000 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03388606 · 4,100 participants
Characterization and Treatment of Adolescent Depression
- NCT06593353 · 4,165 participants · NA
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia